We are live on ! Find out more
HPCM

High Pointe Capital Management Portfolio holdings

AUM $139M
1-Year Est. Return 24.99%
This Fund
S&P 500
This Quarter Est. Return
+19.99%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
AUM
$76.1M
AUM Growth
+$5.91M
Cap. Flow
-$3.49M
Cap. Flow %
-4.59%
Top 10 Hldgs %
32.31%
Holding
93
New
20
Increased
Reduced
33
Closed
16

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$1.49M
2
MOH icon
Molina Healthcare
MOH
+$1.48M
3
KGC icon
Kinross Gold
KGC
+$1.28M
4
LOW icon
Lowe's Companies
LOW
+$986K
5
MRK icon
Merck
MRK
+$935K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.12M
2
CVX icon
Chevron
CVX
+$1.55M
3
ATVI
Activision Blizzard
ATVI
+$1.52M
4
ELV icon
Elevance Health
ELV
+$1.23M
5
ZD icon
Ziff Davis
ZD
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 20.34%
2 Materials 18.44%
3 Financials 14.06%
4 Technology 10.9%
5 Communication Services 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$617B
$1.06M 1.39%
7,510
-180
-2% -$26.2K
CW icon
27
Curtiss-Wright
CW
$26.5B
$1.03M 1.36%
11,555
-510
-4% -$48.6K
KL
28
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1.02M 1.34%
24,710
CTLT
29
DELISTED
CATALENT, INC.
CTLT
$965K 1.27%
13,170
-10,720
-45% -$728K
STT icon
30
State Street
STT
$50.2B
$957K 1.26%
+15,060
New +$909K
SCHW
31
Charles Schwab
SCHW
$181B
$942K 1.24%
27,910
AXP icon
32
American Express
AXP
$228B
$922K 1.21%
+9,680
New +$891K
MRK icon
33
Merck
MRK
$321B
$916K 1.2%
+12,419
New +$935K
BKNG icon
34
Booking.com
BKNG
$150B
$908K 1.19%
+14,250
New +$868K
SYK icon
35
Stryker
SYK
$133B
$870K 1.14%
+4,830
New +$891K
ATVI
36
DELISTED
Activision Blizzard
ATVI
$849K 1.12%
11,190
-21,760
-66% -$1.52M
A icon
37
Agilent Technologies
A
$39.2B
$835K 1.1%
9,450
-1,120
-11% -$91.8K
NTR icon
38
Nutrien
NTR
$33.9B
$830K 1.09%
25,860
-1,590
-6% -$55.3K
ALXN
39
DELISTED
Alexion Pharmaceuticals
ALXN
$825K 1.08%
7,350
BIIB icon
40
Biogen
BIIB
$30.7B
$821K 1.08%
+3,070
New +$923K
CTVA icon
41
Corteva
CTVA
$59.8B
$811K 1.07%
+30,290
New +$788K
WAB icon
42
Wabtec
WAB
$49.4B
$796K 1.05%
+13,820
New +$783K
HUM icon
43
Humana
HUM
$44B
$744K 0.98%
+1,920
New +$718K
EHC icon
44
Encompass Health
EHC
$11B
$733K 0.96%
14,870
-1,207
-8% -$65.1K
RJA
45
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$731K 0.96%
148,090
PM icon
46
Philip Morris
PM
$299B
$675K 0.89%
9,630
-820
-8% -$59.8K
RTX icon
47
RTX Corp
RTX
$289B
$651K 0.86%
10,561
-11,971
-53% -$747K
BWA icon
48
BorgWarner
BWA
$13.2B
$633K 0.83%
20,368
OUT icon
49
Outfront Media
OUT
$5.62B
$599K 0.79%
42,966
TSM icon
50
TSMC
TSM
$2.09T
$536K 0.7%
9,440

Similar funds

High Pointe Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, High Pointe Capital Management held 93 positions worth $76.1M, up 8.4% from $70.2M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

High Pointe Capital Management withdrew a net $3.49M in Q2 2020, closing 16 positions and reducing 33 holdings. Its most notable exit was CVS Health, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Materials and Financials.

Against the trend, High Pointe Capital Management opened a new position in Centene worth $1.45M.

  • High Pointe Capital Management's largest Q2 2020 buy was Centene: 22,840 shares worth $1.45M.
  • High Pointe Capital Management's biggest Q2 2020 reduction was Activision Blizzard, cutting an estimated $1.52M.
  • High Pointe Capital Management fully exited CVS Health in Q2 2020, selling an estimated $2.12M.
  • High Pointe Capital Management's ten largest holdings make up 32% of its $76.1M portfolio in Q2 2020.
  • High Pointe Capital Management opened 20 new positions and closed 16 in Q2 2020.
  • High Pointe Capital Management's portfolio value rose 8.4% quarter-over-quarter to $76.1M.

Based on High Pointe Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.